Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jeffrey S. Heier Insider Profile
11 Followers
Jeffrey S. Heier, CSO at Ocular Therapeutix, holds 269.06K shares in Ocular Therapeutix (Ticker: OCUL). Most recently, Jeffrey S. Heier Sold $2,948 shares of Ocular Therapeutix on Nov 27, 2024 for an estimated value of 26.56K.
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+38.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Jeffrey S. Heier's holdings
Insider Roles
CSO
Roles that Jeffrey S. Heier holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jeffrey S. Heier
Jeffrey S. Heier's Trading History
List of latest transactions for each holding click on a transaction to see Jeffrey S. Heier's performance on stock
You May Also Like
Jeffrey S. Heier insider profile FAQ
What is the percentage of profitable transactions made by Jeffrey S. Heier?
The percentage of profitable transactions made by Jeffrey S. Heier is 100%.
What is the average return per transaction made by Jeffrey S. Heier?
The average return per transaction made by Jeffrey S. Heier is 38.50%.
What stocks does Jeffrey S. Heier hold?
Jeffrey S. Heier holds: OCUL stocks.
What was Jeffrey S. Heier’s latest transaction?
Jeffrey S. Heier latest transaction was an Informative Sell of $26.56K.
What was Jeffrey S. Heier's most profitable transaction?
Jeffrey S. Heier’s most profitable transaction was an Informative Buy of OCUL stock on May 16, 2022. The return on the trade was 85.70%.
What is Jeffrey S. Heier's role in Ocular Therapeutix?
Jeffrey S. Heier's role in Ocular Therapeutix is CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.